English
简体中文
Total: £ 56.28
Published Date: 2026-03-20 | Pages: 127 | Tables: 138 | Medical Care
The global Radiolabelled ADME Studies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Radiolabelled ADME studies utilize radiolabelled (radioactive) versions of a drug to track its journey through the body. The radioactive label allows for precise detection and quantification of the drug and its metabolites, facilitating a comprehensive understanding of its pharmacokinetic profile.
The North American market for Radiolabelled ADME Studies is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Radiolabelled ADME Studies is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Radiolabelled ADME Studies in Biopharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Radiolabelled ADME Studies include Charles River, Eurofins Scientific, Evotec, Labcorp, Sekisui Medical, XenoTech (BioIVT), QPS, BioDuro-Sundia, Quotient Sciences, Chelatec, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Radiolabelled ADME Studies market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Radiolabelled ADME Studies. The Radiolabelled ADME Studies market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Radiolabelled ADME Studies market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Radiolabelled ADME Studies manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Charles River
Eurofins Scientific
Evotec
Labcorp
Sekisui Medical
XenoTech (BioIVT)
QPS
BioDuro-Sundia
Quotient Sciences
Chelatec
HMR
Nuvisan
Fluorizon
WuXi AppTec
Pharmaron
InnoStar
Medicilon
Frontage
Value Pharmaceutical
New Radiomedicine Technology
Segment by Type
C-14
H-3
Others
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Radiolabelled ADME Studies companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiolabelled ADME Studies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 C-14
1.2.3 H-3
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiolabelled ADME Studies Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiolabelled ADME Studies Market Perspective (2021–2032)
2.2 Global Radiolabelled ADME Studies Growth Trends by Region
2.2.1 Global Radiolabelled ADME Studies Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Radiolabelled ADME Studies Historic Market Size by Region (2021–2026)
2.2.3 Radiolabelled ADME Studies Forecasted Market Size by Region (2027–2032)
2.3 Radiolabelled ADME Studies Market Dynamics
2.3.1 Radiolabelled ADME Studies Industry Trends
2.3.2 Radiolabelled ADME Studies Market Drivers
2.3.3 Radiolabelled ADME Studies Market Challenges
2.3.4 Radiolabelled ADME Studies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiolabelled ADME Studies Players by Revenue
3.1.1 Global Top Radiolabelled ADME Studies Players by Revenue (2021–2026)
3.1.2 Global Radiolabelled ADME Studies Revenue Market Share by Players (2021–2026)
3.2 Global Top Radiolabelled ADME Studies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Radiolabelled ADME Studies Revenue
3.4 Global Radiolabelled ADME Studies Market Concentration Ratio
3.4.1 Global Radiolabelled ADME Studies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiolabelled ADME Studies Revenue in 2025
3.5 Global Key Players of Radiolabelled ADME Studies Head Offices and Areas Served
3.6 Global Key Players of Radiolabelled ADME Studies, Products and Applications
3.7 Global Key Players of Radiolabelled ADME Studies, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Radiolabelled ADME Studies Breakdown Data by Type
4.1 Global Radiolabelled ADME Studies Historic Market Size by Type (2021–2026)
4.2 Global Radiolabelled ADME Studies Forecasted Market Size by Type (2027–2032)
5 Radiolabelled ADME Studies Breakdown Data by Application
5.1 Global Radiolabelled ADME Studies Historic Market Size by Application (2021–2026)
5.2 Global Radiolabelled ADME Studies Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Radiolabelled ADME Studies Market Size (2021–2032)
6.2 North America Radiolabelled ADME Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Radiolabelled ADME Studies Market Size by Country (2021–2026)
6.4 North America Radiolabelled ADME Studies Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiolabelled ADME Studies Market Size (2021–2032)
7.2 Europe Radiolabelled ADME Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Radiolabelled ADME Studies Market Size by Country (2021–2026)
7.4 Europe Radiolabelled ADME Studies Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Radiolabelled ADME Studies Market Size (2021–2032)
8.2 Asia-Pacific Radiolabelled ADME Studies Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2021–2026)
8.4 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Radiolabelled ADME Studies Market Size (2021–2032)
9.2 Latin America Radiolabelled ADME Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Radiolabelled ADME Studies Market Size by Country (2021–2026)
9.4 Latin America Radiolabelled ADME Studies Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiolabelled ADME Studies Market Size (2021–2032)
10.2 Middle East & Africa Radiolabelled ADME Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2021–2026)
10.4 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiolabelled ADME Studies Introduction
11.1.4 Charles River Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.1.5 Charles River Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Radiolabelled ADME Studies Introduction
11.2.4 Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.2.5 Eurofins Scientific Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Radiolabelled ADME Studies Introduction
11.3.4 Evotec Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.3.5 Evotec Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Details
11.4.2 Labcorp Business Overview
11.4.3 Labcorp Radiolabelled ADME Studies Introduction
11.4.4 Labcorp Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.4.5 Labcorp Recent Development
11.5 Sekisui Medical
11.5.1 Sekisui Medical Company Details
11.5.2 Sekisui Medical Business Overview
11.5.3 Sekisui Medical Radiolabelled ADME Studies Introduction
11.5.4 Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.5.5 Sekisui Medical Recent Development
11.6 XenoTech (BioIVT)
11.6.1 XenoTech (BioIVT) Company Details
11.6.2 XenoTech (BioIVT) Business Overview
11.6.3 XenoTech (BioIVT) Radiolabelled ADME Studies Introduction
11.6.4 XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.6.5 XenoTech (BioIVT) Recent Development
11.7 QPS
11.7.1 QPS Company Details
11.7.2 QPS Business Overview
11.7.3 QPS Radiolabelled ADME Studies Introduction
11.7.4 QPS Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.7.5 QPS Recent Development
11.8 BioDuro-Sundia
11.8.1 BioDuro-Sundia Company Details
11.8.2 BioDuro-Sundia Business Overview
11.8.3 BioDuro-Sundia Radiolabelled ADME Studies Introduction
11.8.4 BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.8.5 BioDuro-Sundia Recent Development
11.9 Quotient Sciences
11.9.1 Quotient Sciences Company Details
11.9.2 Quotient Sciences Business Overview
11.9.3 Quotient Sciences Radiolabelled ADME Studies Introduction
11.9.4 Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.9.5 Quotient Sciences Recent Development
11.10 Chelatec
11.10.1 Chelatec Company Details
11.10.2 Chelatec Business Overview
11.10.3 Chelatec Radiolabelled ADME Studies Introduction
11.10.4 Chelatec Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.10.5 Chelatec Recent Development
11.11 HMR
11.11.1 HMR Company Details
11.11.2 HMR Business Overview
11.11.3 HMR Radiolabelled ADME Studies Introduction
11.11.4 HMR Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.11.5 HMR Recent Development
11.12 Nuvisan
11.12.1 Nuvisan Company Details
11.12.2 Nuvisan Business Overview
11.12.3 Nuvisan Radiolabelled ADME Studies Introduction
11.12.4 Nuvisan Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.12.5 Nuvisan Recent Development
11.13 Fluorizon
11.13.1 Fluorizon Company Details
11.13.2 Fluorizon Business Overview
11.13.3 Fluorizon Radiolabelled ADME Studies Introduction
11.13.4 Fluorizon Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.13.5 Fluorizon Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Radiolabelled ADME Studies Introduction
11.14.4 WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.14.5 WuXi AppTec Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Radiolabelled ADME Studies Introduction
11.15.4 Pharmaron Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.15.5 Pharmaron Recent Development
11.16 InnoStar
11.16.1 InnoStar Company Details
11.16.2 InnoStar Business Overview
11.16.3 InnoStar Radiolabelled ADME Studies Introduction
11.16.4 InnoStar Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.16.5 InnoStar Recent Development
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Radiolabelled ADME Studies Introduction
11.17.4 Medicilon Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.17.5 Medicilon Recent Development
11.18 Frontage
11.18.1 Frontage Company Details
11.18.2 Frontage Business Overview
11.18.3 Frontage Radiolabelled ADME Studies Introduction
11.18.4 Frontage Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.18.5 Frontage Recent Development
11.19 Value Pharmaceutical
11.19.1 Value Pharmaceutical Company Details
11.19.2 Value Pharmaceutical Business Overview
11.19.3 Value Pharmaceutical Radiolabelled ADME Studies Introduction
11.19.4 Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.19.5 Value Pharmaceutical Recent Development
11.20 New Radiomedicine Technology
11.20.1 New Radiomedicine Technology Company Details
11.20.2 New Radiomedicine Technology Business Overview
11.20.3 New Radiomedicine Technology Radiolabelled ADME Studies Introduction
11.20.4 New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2021–2026)
11.20.5 New Radiomedicine Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radiolabelled ADME Studies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of C-14
Table 3. Key Players of H-3
Table 4. Key Players of Others
Table 5. Global Radiolabelled ADME Studies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Radiolabelled ADME Studies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Radiolabelled ADME Studies Market Size by Region (US$ Million), 2021–2026
Table 8. Global Radiolabelled ADME Studies Market Share by Region (2021–2026)
Table 9. Global Radiolabelled ADME Studies Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Radiolabelled ADME Studies Market Share by Region (2027–2032)
Table 11. Radiolabelled ADME Studies Market Trends
Table 12. Radiolabelled ADME Studies Market Drivers
Table 13. Radiolabelled ADME Studies Market Challenges
Table 14. Radiolabelled ADME Studies Market Restraints
Table 15. Global Radiolabelled ADME Studies Revenue by Players (US$ Million), 2021–2026
Table 16. Global Radiolabelled ADME Studies Market Share by Players (2021–2026)
Table 17. Global Top Radiolabelled ADME Studies Players by Tier (Tier 1, Tier 2, and Tier 3), based on Radiolabelled ADME Studies Revenue, 2025
Table 18. Ranking of Global Top Radiolabelled ADME Studies Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Radiolabelled ADME Studies Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Radiolabelled ADME Studies, Headquarters and Area Served
Table 21. Global Key Players of Radiolabelled ADME Studies, Products and Applications
Table 22. Global Key Players of Radiolabelled ADME Studies, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Radiolabelled ADME Studies Market Size by Type (US$ Million), 2021–2026
Table 25. Global Radiolabelled ADME Studies Revenue Market Share by Type (2021–2026)
Table 26. Global Radiolabelled ADME Studies Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Radiolabelled ADME Studies Revenue Market Share by Type (2027–2032)
Table 28. Global Radiolabelled ADME Studies Market Size by Application (US$ Million), 2021–2026
Table 29. Global Radiolabelled ADME Studies Revenue Market Share by Application (2021–2026)
Table 30. Global Radiolabelled ADME Studies Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Radiolabelled ADME Studies Revenue Market Share by Application (2027–2032)
Table 32. North America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Radiolabelled ADME Studies Market Size by Country (US$ Million), 2021–2026
Table 34. North America Radiolabelled ADME Studies Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Radiolabelled ADME Studies Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Radiolabelled ADME Studies Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Radiolabelled ADME Studies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Radiolabelled ADME Studies Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Radiolabelled ADME Studies Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (US$ Million), 2027–2032
Table 47. Charles River Company Details
Table 48. Charles River Business Overview
Table 49. Charles River Radiolabelled ADME Studies Product
Table 50. Charles River Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 51. Charles River Recent Development
Table 52. Eurofins Scientific Company Details
Table 53. Eurofins Scientific Business Overview
Table 54. Eurofins Scientific Radiolabelled ADME Studies Product
Table 55. Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 56. Eurofins Scientific Recent Development
Table 57. Evotec Company Details
Table 58. Evotec Business Overview
Table 59. Evotec Radiolabelled ADME Studies Product
Table 60. Evotec Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 61. Evotec Recent Development
Table 62. Labcorp Company Details
Table 63. Labcorp Business Overview
Table 64. Labcorp Radiolabelled ADME Studies Product
Table 65. Labcorp Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 66. Labcorp Recent Development
Table 67. Sekisui Medical Company Details
Table 68. Sekisui Medical Business Overview
Table 69. Sekisui Medical Radiolabelled ADME Studies Product
Table 70. Sekisui Medical Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 71. Sekisui Medical Recent Development
Table 72. XenoTech (BioIVT) Company Details
Table 73. XenoTech (BioIVT) Business Overview
Table 74. XenoTech (BioIVT) Radiolabelled ADME Studies Product
Table 75. XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 76. XenoTech (BioIVT) Recent Development
Table 77. QPS Company Details
Table 78. QPS Business Overview
Table 79. QPS Radiolabelled ADME Studies Product
Table 80. QPS Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 81. QPS Recent Development
Table 82. BioDuro-Sundia Company Details
Table 83. BioDuro-Sundia Business Overview
Table 84. BioDuro-Sundia Radiolabelled ADME Studies Product
Table 85. BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 86. BioDuro-Sundia Recent Development
Table 87. Quotient Sciences Company Details
Table 88. Quotient Sciences Business Overview
Table 89. Quotient Sciences Radiolabelled ADME Studies Product
Table 90. Quotient Sciences Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 91. Quotient Sciences Recent Development
Table 92. Chelatec Company Details
Table 93. Chelatec Business Overview
Table 94. Chelatec Radiolabelled ADME Studies Product
Table 95. Chelatec Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 96. Chelatec Recent Development
Table 97. HMR Company Details
Table 98. HMR Business Overview
Table 99. HMR Radiolabelled ADME Studies Product
Table 100. HMR Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 101. HMR Recent Development
Table 102. Nuvisan Company Details
Table 103. Nuvisan Business Overview
Table 104. Nuvisan Radiolabelled ADME Studies Product
Table 105. Nuvisan Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 106. Nuvisan Recent Development
Table 107. Fluorizon Company Details
Table 108. Fluorizon Business Overview
Table 109. Fluorizon Radiolabelled ADME Studies Product
Table 110. Fluorizon Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 111. Fluorizon Recent Development
Table 112. WuXi AppTec Company Details
Table 113. WuXi AppTec Business Overview
Table 114. WuXi AppTec Radiolabelled ADME Studies Product
Table 115. WuXi AppTec Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 116. WuXi AppTec Recent Development
Table 117. Pharmaron Company Details
Table 118. Pharmaron Business Overview
Table 119. Pharmaron Radiolabelled ADME Studies Product
Table 120. Pharmaron Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 121. Pharmaron Recent Development
Table 122. InnoStar Company Details
Table 123. InnoStar Business Overview
Table 124. InnoStar Radiolabelled ADME Studies Product
Table 125. InnoStar Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 126. InnoStar Recent Development
Table 127. Medicilon Company Details
Table 128. Medicilon Business Overview
Table 129. Medicilon Radiolabelled ADME Studies Product
Table 130. Medicilon Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 131. Medicilon Recent Development
Table 132. Frontage Company Details
Table 133. Frontage Business Overview
Table 134. Frontage Radiolabelled ADME Studies Product
Table 135. Frontage Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 136. Frontage Recent Development
Table 137. Value Pharmaceutical Company Details
Table 138. Value Pharmaceutical Business Overview
Table 139. Value Pharmaceutical Radiolabelled ADME Studies Product
Table 140. Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 141. Value Pharmaceutical Recent Development
Table 142. New Radiomedicine Technology Company Details
Table 143. New Radiomedicine Technology Business Overview
Table 144. New Radiomedicine Technology Radiolabelled ADME Studies Product
Table 145. New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (US$ Million), 2021–2026
Table 146. New Radiomedicine Technology Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Radiolabelled ADME Studies Picture
Figure 2. Global Radiolabelled ADME Studies Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Radiolabelled ADME Studies Market Share by Type: 2025 vs 2032
Figure 4. C-14 Features
Figure 5. H-3 Features
Figure 6. Others Features
Figure 7. Global Radiolabelled ADME Studies Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Radiolabelled ADME Studies Market Share by Application: 2025 vs 2032
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Government and Academic Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Radiolabelled ADME Studies Report Years Considered
Figure 13. Global Radiolabelled ADME Studies Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Radiolabelled ADME Studies Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Radiolabelled ADME Studies Market Share by Region: 2025 vs 2032
Figure 16. Global Radiolabelled ADME Studies Market Share by Players in 2025
Figure 17. Global Radiolabelled ADME Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Radiolabelled ADME Studies Revenue in 2025
Figure 19. North America Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Radiolabelled ADME Studies Market Share by Country (2021–2032)
Figure 21. United States Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Radiolabelled ADME Studies Market Share by Country (2021–2032)
Figure 25. Germany Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Radiolabelled ADME Studies Market Share by Region (2021–2032)
Figure 33. China Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Radiolabelled ADME Studies Market Share by Country (2021–2032)
Figure 41. Mexico Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Radiolabelled ADME Studies Market Share by Country (2021–2032)
Figure 45. Israel Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Radiolabelled ADME Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Charles River Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 49. Eurofins Scientific Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 50. Evotec Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 51. Labcorp Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 52. Sekisui Medical Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 53. XenoTech (BioIVT) Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 54. QPS Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 55. BioDuro-Sundia Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 56. Quotient Sciences Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 57. Chelatec Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 58. HMR Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 59. Nuvisan Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 60. Fluorizon Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 61. WuXi AppTec Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 62. Pharmaron Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 63. InnoStar Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 64. Medicilon Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 65. Frontage Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 66. Value Pharmaceutical Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 67. New Radiomedicine Technology Revenue Growth Rate in Radiolabelled ADME Studies Business (2021–2026)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
